FdaApplication
NDA 020263
Identifiers
- fda_app_no: NDA020263
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE ENDOCRINE INC |
| application_type | NDA |
| approval_date | 1993-04-16 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 3.75MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 7.5MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 45MG | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 11.25MG | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 30MG | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 11.25MG | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 15MG | POWDER;INTRAMUSCULAR |
| LUPRON DEPOT-PED KIT | LEUPROLIDE ACETATE | 7.5MG | POWDER;INTRAMUSCULAR |
8 products